Regulatory Affairs

AHRA Advocacy

About AHRA Regulatory Affairs

The role of the AHRA Regulatory Affairs Committee is to help our members understand, navigate and implement new or changing regulations that affect our industry and specifically, the medical imaging community. Consistent with the goals of AHRA's Strategic Plan, through participation and interaction with a variety of influential national organizations and alliances, we endeavor to expand awareness of AHRA's presence and participation within the healthcare space as an important and influential industry leader.

The mission of AHRA's Regulatory Affairs Committee is to use a systematic approach to evaluate proposed legislation, regulations and budget rules that impact medical imaging. The Committee may also evaluate alliances, partnerships, or coalitions. Existing arrangements will be evaluated annually to ensure that partnerships, alliances, or coalitions further the goals of the organizations stated in the Strategic Plan. All alliances, partnerships or coalitions must include activities to promote the goals of the AHRA. Have a regulatory question? Ask your fellow AHRA Members in the Regulatory and Reimbursement community in Connect!

Health Policy Newsletter 

Senate Scrutinizes 340B Drug Discount Program

On October 23, 2025, the Senate Health, Education, Labor, and Pensions (HELP) Committee held a hearing on the 340B Drug Pricing Program. This hearing served several purposes including: (1) defining this program’s original intent, (2) addressing its continual growth, (3) underscoring its impact on patients, and (4) offering potential reform options. Despite the proposal of some reforms, lawmakers did not reach any decisive conclusions about a path forward.  

Read More

Previous Newsletters

Latest News

HHS Finalizes Sweeping Non-Discrimination Rule

The Department of Health and Human Services (HHS), through the Office of Civil Rights (OCR) recently released a final rule regarding section... Read More

Official Communications & Comment Letters

2024 IPPS Proposed Rule

2024 OPPS Comments

2024 PFS Comments

View More